Can Statins Suppress the Development of Abdominal Aortic Aneurysms? A Review of the Current Evidence

Abstract

Statins possess several pleiotropic effects and have been shown in vitro and in vivo to inhibit the expression of inflammatory mediators and downregulate molecules involved in extracellular matrix (ECM) degradation. Recent observational studies in humans suggest that statins may have a role in abdominal aortic aneurysm (AAA) prevention or may even inhibit aneurysm expansion. In this review, we summarize the effects of statins on the vessel wall of aneurysmal aortas and currently available data concerning their inhibitory effects on aneurysm progression.

Keywords

statins abdominal aortic aneurysm pleiotropic effects pharmaceutical treatment

Get full access to this article

View all access options for this article.

References

Nagashima H. , Aoka Y. , Sakomura Y. , et al. A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall. J Vasc Surg. 2002;36(1):158-163.

Aikawa M. , Rabkin E. , Sugiyama S. , et al. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation. 2001; 103(2):276-283.

Baxter BT , Terrin MC , Dalman RL Medical management of small abdominal aortic aneurysms. Circulation . 2008; 117(14):1883-1889.

Paraskevas KI , Stathopoulos V. , Mikhailidis DP Pleiotropic effects of statins: implications for a wide range of diseases. Curr Vasc Pharmacol. 2008;6(4):237-239.

Huang KC , Chen CW , Chen JC , Lin WW HMG-CoA reductase inhibitors inhibit inducible nitric oxide synthase gene expression in macrophages. J Biomed Sci. 2003 ;10(4):396-405.

Hirsch AT , Haskal ZJ , Hertzer NR , et al. ACC/AHA practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary. Circulation. 2006 ;113(11):e463-e654.

Leurs LJ , Visser P. , Laheij RJ , Buth J. , Harris PL , Blankensteijn JD Statin use is associated with reduced all-cause mortality after endovascular abdominal aortic aneurysm repair. Vascular. 2006;14:1-8.

Kalyanasundaram A. , Elmore JR , Manazer JR , et al. Simvastatin suppresses experimental aortic aneurysm expansion. J Vasc Surg. 2006 ;43(1):117-124.

Steinmetz EF , Buckley C. , Shames ML Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice. Ann Surg. 2005;241(1):92-101.

10.

Pearce WH , Shively VP Abdominal aortic aneurysm as a complex multifactorial disease: interactions of polymorphisms of inflammatory genes, features of autoimmunity, and current status of MMPs. Ann N Y Acad Sci. 2006;1085:117-132.

11.

Annambhotla S. , Bourgeois S. , Wang X. , Lin PH , Yao Q. , Chen C. Recent advances in molecular mechanisms of abdominal aortic aneurysm formation. World J Surg. 2008;32(6):976-986.

12.

Neptune ER , Frischmeyer PA , Arking DE , et al. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet. 2003; 33(3):407-411.

13.

Maleszewski JJ , Miller DV , Lu J. , Dietz HC , Halushka MK Histopathologic findings in ascending aortas from individuals with Loeys-Dietz Syndrome (LDS). Am J Surg Pathol.. 2009;33(2):194-201.

14.

Thompson RW , Curci JA , Ennis TL , Mao D. , Pagano MB , Pham CT Pathophysiology of abdominal aortic aneurysms: insights from the elastase-induced model in mice with different genetic backgrounds . Ann N Y Acad Sci. 2006;1085:59-73.

15.

Wills A. , Thompson MM , Crowther M. , et al. Elastase-induced matrix degradation in arterial organ cultures: an in vitro model of aneurysmal disease. J Vasc Surg. 1996;24(4):667-679.

16.

Anidjar S. , Salzmann JL , Gentric D. , Lagneau P. , Camilleri JP , Michel JB Elastase-induced experimental aneurysms in rats. Circulation . 1990;82(3):973-981.

17.

Thompson RW , Parks WC Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann N Y Acad Sci. 1996;800:157-174.

18.

Newman KM , Ogata Y. , Malon AM , et al. Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm. Arterioscler Thromb. 1994;14(8):1315-1320.

19.

Aoki H. , Yoshimura K. , Matsuzaki M. Turning back the clock: regression of abdominal aortic aneurysms via pharmacotherapy . J Mol Med. 2007;85(10):1077-1088.

20.

Yoshimura K. , Aoki H. , Ikeda Y. , Furutani A. , Hamano K. , Matsuzaki M. Identification of c-Jun N-terminal kinase as a therapeutic target for abdominal aortic aneurysm. Ann N Y Acad Sci. 2006;1085:403-406.

21.

Cassis LA , Helton MJ , Howatt DA , King VL , Daugherty A. Aldosterone does not mediate angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Br J Pharmacol. 2005;144(3):443-448.

22.

Rupérez M. , Rodrigues-Díez R. , Blanco-Colio LM , et al. HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways. Hypertension. 2007;50(2):377-383.

23.

Lu H. , Rateri DL , Cassis LA , Daugherty A. The role of the renin-angiotensin system in aortic aneurysmal diseases. Curr Hypertens Rep. 2008;10(2):99-106.

24.

Middleton RK , Lloyd GM , Bown MJ , Cooper NJ , London NJ , Sayers RD The proinflammatory and chemotactic cytokine microenvironment of the abdominal aortic aneurysm wall: a protein array study . J Vasc Surg. 2007;45(3):574-580.

25.

Colonnello JS , Hance KA , Shames ML , et al. Transient exposure to elastase induces mouse aortic wall smooth muscle cell production of MCP-1 and RANTES during development of experimental aortic aneurysm. J Vasc Surg. 2003;38(1):138-146.

26.

Chapple KS , Parry DJ , McKenzie S. , MacLennan KA , Jones P. , Scott DJ Cyclooxygenase-2 expression and its association with increased angiogenesis in human abdominal aortic aneurysms. Ann Vasc Surg. 2007; 21(1):61-66.

27.

Sukhova GK , Shi GP Do cathepsins play a role in abdominal aortic aneurysm pathogenesis? Ann N Y Acad Sci. 2006;1085:161-169.

28.

Lutgens SP , Cleutjens KB , Daemen MJ , Heeneman S. Cathepsin cysteine proteases in cardiovascular disease. FASEB J. 2007;21(12):3029-3041.

29.

Abisi S. , Burnand KG , Waltham M. , Humphries J. , Taylor PR , Smith A. Cysteine protease activity in the wall of abdominal aortic aneurysms. J Vasc Surg. 2007;46(6): 1260-1266.

30.

Golledge J. , Muller J. , Shephard N. , et al. Association between osteopontin and human abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 2007;27(3): 655-660.

31.

Aoki T. , Kataoka H. , Shimamura M. , et al. NF-kappaB is a key mediator of cerebral aneurysm formation. Circulation. 2007;116(24):2830-2840.

32.

Iribarren C. , Darvinian JA , Go AS , Fireman BH , Lee CD , Grey DP Traditional and novel risk factors for clinically diagnosed abdominal aortic aneurysm: the Kaiser multi-phasic health checkup cohort study. Ann Epidemiol. 2007;17(9):669-678.

33.

Lindholt JS , Heegaard NH , Vammen S. , Fasting H. , Henneberg EW , Heickendorff L. Smoking, but not lipids, lipoprotein(a) and antibodies against oxidised LDL, is correlated to the expansion of abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2001;21(1):51-56.

34.

MacSweeney ST , Ellis M. , Worrell PC , Greenhalgh RM , Powell JT Smoking and growth rate of small abdominal aortic aneurysms. Lancet. 1994;344(8923):651-652.

35.

Aoki T. , Kataoka H. , Ishibashi R. , Nozaki K. , Hashimoto N. Simvastatin suppresses the progression of experimentally induced cerebral aneurysms in rats. Stroke. 2008; 39(4):1276-1285.

36.

Nabatov AA , Pollakis G. , Linnemann T. , Paxton WA , de Baar MP Statins disrupt CCR5 and RANTES expression levels in CD4+ T lymphocytes in vitro and preferentially decrease infection of R5 versus X4 HIV-1. PLoS ONE. 2007;2(5):e470.

37.

Kim YS , Ahn Y. , Hong MH , et al. Rosuvastatin suppresses the inflammatory responses through inhibition of c-Jun N-terminal kinase and nuclear factor-kappaB in endothelial cells . J Cardiovasc Pharmacol. 2007;49(6): 376-383.

38.

Wilson WR , Evans J. , Bell PR , Thompson MM HMGCoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2005;30(3):259-262.

39.

Luan Z. , Chase AJ , Newby AC Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages. Arterioscler Thromb Vasc Biol. 2003;23(5):769-775.

40.

Abisi S. , Burnand KG , Humphries J. , Waltham M. , Taylor P. , Smith A. Effect of statins on proteolytic activity in the wall of abdominal aortic aneurysms. Br J Surg. 2008;95(3):333-337.

41.

Shiraya S. , Miyake T. , Aoki M. Inhibition of development of experimental aortic abdominal aneurysm in rat model by atorvastatin through inhibition of macrophage migration. Atherosclerosis . 2009;202(1):34-40.

42.

Habib A. , Shamseddeen I. , Nasrallah MS , et al. Modulation of COX-2 expression by statins in human monocytic cells. FASEB J. 2007;21(8):1665-1674.

43.

Tanaka N. , Momiyama Y. , Ohmori R. , et al. Effect of atorvastatin on plasma osteopontin levels in patients with hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2006;26(8):e129-e130.

44.

45.

Ye P. , Yu D. , Song L. , Deng X. , Zhao Y. Inhibitory effect of fluvastatin on aortic intimal thickening in normocholesterolemic rabbits. Chin Med Sci J. 2000;15(3):140-144.

46.

Henderson EL , Geng YJ , Sukhova GK , Whittemore AD , Knox J. , Libby P. Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms . Circulation. 1999;99(1):96-104.

47.

Takahashi M. , Ogata Y. , Okazaki H. , et al. Fluvastatin enhances apoptosis in cytokine-stimulated vascular smooth muscle cells. J Cardiovasc Pharmacol. 2002; 39(2):310-317.

48.

Tsujimoto A. , Takemura G. , Mikami A. , et al. A therapeutic dose of the lipophilic statin pitavastatin enhances oxidant-induced apoptosis in human vascular smooth muscle cells. J Cardiovasc Pharmacol. 2006 ;48(4): 160-165.

49.

Ogata Y. , Takahashi M. , Takeuchi K. , et al. Fluvastatin induces apoptosis in rat neonatal cardiac myocytes: a possible mechanism of statin-attenuated cardiac hypertrophy. J Cardiovasc Pharmacol. 2002;40(6):907-915.

50.

Evans J. , Powell JT , Schwalbe E. , Loftus IM , Thompson MM Simvastatin Attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue. Eur J Vasc Endovasc Surg. 2007 ;34(3):302-303.

51.

Sukhova GK , Wang B. , Libby P. , et al. Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice. Circ Res . 2005;96(3):368-375.

52.

Saratzis A. , Saratzis N. , Melas N. , Kiskinis D. Pharmacotherapy before and after endovascular repair of abdominal aortic aneurysms. Curr Vasc Pharmacol . 2008;6(4):240-249.

53.

Sukhija R. , Aronow WS , Sandhu R. , Kakar P. , Babu S. Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins. Am J Cardiol. 2006;97(2):279-280.

54.

Mosorin M. , Niemelä E. , Heikkinen J. , et al. The use of statins and fate of small abdominal aortic aneurysms . Interact Cardiovasc Thorac Surg. 2008;7(4):578-581.

55.

Schouten O. , van Laanen JH , Boersma E. , et al. Statins are associated with a reduced infrarenal abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2006;32(1): 21-26.

56.

57.

Wilson WR , Evans J. , Bell PR , Thompson MM HMGCoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2005;30(3):259-262.

58.

Mateos-Cáceres PJ , López-Farré AJ , Morata PC , et al. Pravastatin increases the expression of the tissue inhibitor of matrix metalloproteinase-1 and the oncogene Bax in human aortic abdominal aneurysms. Can J Physiol Pharmacol. 2008;86(7):431-437.

59.

Ihling C. , Szombathy T. , Nampoothiri K. , et al. Cystic medial degeneration of the aorta is associated with p53 accumulation, Bax upregulation, apoptotic cell death, and cell proliferation . Heart. 1999;82(3):286-293.

60.

Hindler K. , Shaw AD , Samuels J. , Fulton S. , Collard CD , Riedel B. Improved postoperative outcomes associated with preoperative statin therapy . Anesthesiology. 2006;105(6):1260-1272.

61.

Paraskevas KI , Liapis CD , Hamilton G. , Mikhailidis DP Can statins reduce perioperative morbidity and mortality in patients undergoing non-cardiac vascular surgery? Eur J Vasc Endovasc Surg. 2006;32(3):286-293.